Market Overview:
The global toxoid market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infectious diseases, rising demand for vaccines, and technological advancements in the field of vaccine production. Based on type, the global toxoid market is segmented into tetanic toxoid, diphtheria toxoid, and others. Tetanic toxoid dominates the global market and is expected to grow at a CAGR of 5.8% from 2018 to 2030 due to its high efficacy and safety profile. Diphtheria toxoids are also growing rapidly due their benefits such as prevention against Corynebacterium diphtheriae infection which causes diphtheria disease. Based on application, hospitals account for majority share in terms of revenue followed by clinics in 2017; however clinics are projected to witness highest growth rate during forecast period owing rising awareness about preventive healthcare measures among people coupled with increasing number diagnostic centers across globe .Others segment includes research institutes & universities , contract manufacturing organizations (CMOs) etc .
Product Definition:
A toxoid is a vaccine that uses an inactivated toxin to produce immunity. It is used to prevent diseases caused by bacteria, such as tetanus and diphtheria.
Tetanic Toxoid:
Tetanic toxoid is a vaccine that is used to prevent people from getting sick in the event of an accident or natural disaster. It works by stimulating antibodies against tetanus, a deadly disease caused by bacteria. The product has been proven effective and has been used across the world for decades as it helps protect people from this dangerous illness.
The global tetanus vaccine market was valued at USD 648 million in 2016.
Diphtheria Toxoid:
Diphtheria toxoid is a preparation of the toxin of diphtheria. It is used in making vaccines for protection against diphtheria. Diphtheria vaccine consists of three doses, the first dose should be given within two months of infection and second dose four weeks after the first one and third dose six months after the first two doses.
Application Insights:
The others segment held the largest share of the global toxoid market in 2017. This is due to growing demand for various types of vaccines, especially against diseases that are prevalent in other regions but not covered by existing vaccines such as Japanese encephalitis and typhoid. The Tetanus Toxoid vaccine is most commonly given to patients suffering from injuries or surgeries, which increases its demand globally. However, it does not have any specific application and can be used universally across all age groups.
Hospitals were the second-largest segment accounting for a revenue share of 29% in 2017 owing to increasing awareness about immunization among hospital staff resulting in an increased number of injections being administered at hospitals compared to clinics or other healthcare facilities. Furthermore, government initiatives such as Immunization Services Enhancement (ISE) program implemented through Vaccine Management Information System (VMIS) network across U.S.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high demand for therapeutics is expected to drive the regional growth over the forecast period. In addition, increasing incidence of infectious diseases due to various factors including unhealthy lifestyle and travel is also anticipated to boost product demand in North America.
Asia Pacific region is estimated to witness lucrative growth over the forecast period owing to rising awareness about immunization programs and growing healthcare expenditure by governments as well as private sectors across countries such as China, India, Japan, South Korea & Australia among others.
Moreover Tetra Bio-Pharma Inc.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the toxoid market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of symptoms such as fever, diarrhea, vomiting, and skin rashes. The increasing incidence of these infections is driving the demand for toxoid products worldwide.
- Growing awareness about preventive measures: There is a growing awareness among people about preventive measures against infectious diseases. This has led to an increase in the demand for toxoid products worldwide. Toxoids are effective in preventing many serious infections caused by bacteria and viruses and thus play an important role in public health programs across the globe.
- Technological advancements: The development of new technologies has led to the introduction of novel toxoid products in the market that offer better protection against various types of infections caused by pathogens such as bacteria and viruses. This is contributing to the growth ofthe global toxoid market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Toxoid Market Research Report
By Type
Tetanic Toxoid, Diphtheria Toxoid, Others
By Application
Hospitals, Clinics, Others
By Companies
Biocompare, GSK, Zoetis, Sanofi, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Toxoid Market Report Segments:
The global Toxoid market is segmented on the basis of:
Types
Tetanic Toxoid, Diphtheria Toxoid, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biocompare
- GSK
- Zoetis
- Sanofi
- Merck
Highlights of The Toxoid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tetanic Toxoid
- Diphtheria Toxoid
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Toxoid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Toxoid is a toxin that is created when an organism such as a bacterium or virus attacks another organism. The toxoid can be used to create immunity against the toxin.
Some of the key players operating in the toxoid market are Biocompare, GSK, Zoetis, Sanofi, Merck.
The toxoid market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Toxoid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Toxoid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Toxoid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Toxoid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Toxoid Market Size & Forecast, 2018-2028
4.5.1 Toxoid Market Size and Y-o-Y Growth
4.5.2 Toxoid Market Absolute $ Opportunity
Chapter 5 Global Toxoid Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Toxoid Market Size Forecast by Type
5.2.1 Tetanic Toxoid
5.2.2 Diphtheria Toxoid
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Toxoid Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Toxoid Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Toxoid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Toxoid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Toxoid Analysis and Forecast
9.1 Introduction
9.2 North America Toxoid Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Toxoid Market Size Forecast by Type
9.6.1 Tetanic Toxoid
9.6.2 Diphtheria Toxoid
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Toxoid Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Toxoid Analysis and Forecast
10.1 Introduction
10.2 Europe Toxoid Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Toxoid Market Size Forecast by Type
10.6.1 Tetanic Toxoid
10.6.2 Diphtheria Toxoid
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Toxoid Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Toxoid Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Toxoid Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Toxoid Market Size Forecast by Type
11.6.1 Tetanic Toxoid
11.6.2 Diphtheria Toxoid
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Toxoid Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Toxoid Analysis and Forecast
12.1 Introduction
12.2 Latin America Toxoid Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Toxoid Market Size Forecast by Type
12.6.1 Tetanic Toxoid
12.6.2 Diphtheria Toxoid
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Toxoid Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Toxoid Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Toxoid Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Toxoid Market Size Forecast by Type
13.6.1 Tetanic Toxoid
13.6.2 Diphtheria Toxoid
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Toxoid Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Toxoid Market: Competitive Dashboard
14.2 Global Toxoid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biocompare
14.3.2 GSK
14.3.3 Zoetis
14.3.4 Sanofi
14.3.5 Merck
